Pharmaceutical company AstraZeneca may be conducting another study of its COVID-19 vaccine after accidental lower dose shows higher efficacy. The company’s CEO Pascal Soriot, told Bloomberg that the pharmaceutical company will likely conduct another global trial of the effectiveness of its COVID-19 vaccine trial. This follows the disclosure that the more effective dosage in the … Continue reading “AstraZeneca Says Another COVID-19 Vaccine Study is Likely”
Tag: coronavirus vaccine
Biotech & Pharma
Moderna Files for Emergency Use Authorization for COVID-19 Vaccine
Moderna announced this week the details of its Phase 3 results and has noted that…
December 1, 2020
Biotech & Pharma
Pfizer Now Says Coronavirus Vaccine is 95% Effective and Has Passed Safety Checks
The race is on for a coronavirus vaccine to hit the market as cases continue…
November 19, 2020
Biotech & Pharma
Moderna Reveals its Vaccine for Coronavirus is 94.5% Effective
As the U.S. sets new record for daily coronavirus cases, Moderna has released a preview…
November 17, 2020
Biotech & Pharma
Novavax Announces Deal to Expand Facilities as Company Works on Covid-19 Vaccine Candidate
American vaccine development company Novavax announced two deals this week to expand its manufacturing and…
November 3, 2020
Biotech & Pharma
Moderna Shares Explode as Company Collects Revenue on Covid Drug
Shares of Massachusetts-based biotech company Moderna were headed higher in Thursday's trading session after the…
October 30, 2020
Biotech & Pharma
AstraZeneca Pauses Late Stage COVID-19 Vaccine Trial
Wall Street learned on Tuesday that multinational pharmaceutical giant AstraZeneca has paused a late-stage trial…
September 8, 2020
Biotech & Pharma
Moderna Reveals its Coronavirus Vaccine Has had Promising Results
Biotech company Moderna has revealed this week that its coronavirus vaccine has shown promising results…
August 27, 2020
Biotech & Pharma
Johnson & Johnson to Start Late-stage Coronavirus Vaccine Trial Next Month
Johnson & Johnson announced on Thursday that it would begin largest, late-stage trial testing a…
August 21, 2020
Biotech & Pharma
President Trump Signs $1.5B Deal with Moderna for 100 Million Doses of Coronavirus Vaccine
This week President Trump announced that the U.S. government has signed a $1.5 billion deal…
August 12, 2020
Biotech & Pharma
Big Pharma Giant Merck Explodes on Earnings Beat
Shares of pharmaceutical firm Merck were heading higher after the company reported second-quarter sales of…
August 4, 2020
Biotech & PharmaLuxury
The United States Will Pay This Much to Pfizer and BioNTech for its COVID-19 Vaccine
As coronavirus cases keep surging, the U.S. is prepared to pay a steep amount for…
July 23, 2020
Biotech & Pharma
AstraZeneca’s Experimental COVID-19 Vaccine Looks Promising
With coronavirus cases surging in the U.S., many may feel relief learning that AstraZeneca's experimental…
July 21, 2020
Biotech & Pharma
CEO of Moderna Thinks Company’s COVID-19 Vaccine is Likely to be Successful
Moderna CEO Stéphane Bancel sees ‘high probability’ of success with the company's Covid-19 vaccine. The…
June 19, 2020